Harbor Disruptive Innovation ETF (INNO)

NYSEARCA: INNO · IEX Real-Time Price · USD
12.31
+0.17 (1.42%)
Mar 21, 2023, 4:00 PM EDT - Market closed
1.42%
Assets $8.86M
Expense Ratio 0.75%
PE Ratio 43.90
Shares Out 730,000
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date n/a
Payout Ratio n/a
1-Year Return -24.25%
Volume 796
Open 12.21
Previous Close 12.14
Day's Range 12.21 - 12.31
52-Week Low 10.35
52-Week High 17.15
Beta 1.52
Holdings 95
Inception Date Dec 1, 2021

About INNO

The Harbor Disruptive Innovation ETF (INNO) is an exchange-traded fund that is based on the S&P 500 index. The fund is an actively managed fund that uses a multi-manager approach to invest in global stocks with growth potential tied to disruptive innovation. INNO was launched on Dec 1, 2021 and is managed by Harbor.

Asset Class Equity
Category Mid-Cap Growth
Region North America
Stock Exchange NYSEARCA
Ticker Symbol INNO
Issuer Harbor
Index Tracked S&P 500

Top 10 Holdings

32.90% of assets
Name Symbol Weight
Us Dollar n/a 3.84%
Lam Research Corporation LRCX 3.80%
Workday, Inc. WDAY 3.68%
MercadoLibre, Inc. MELI 3.48%
Adyen NV ADYEN.AS 3.42%
ServiceNow, Inc. NOW 3.38%
Amazon.com, Inc. AMZN 3.15%
Cadence Design Systems, Inc. CDNS 3.11%
Microchip Technology Incorporated MCHP 2.74%
Texas Instruments Incorporated TXN 2.32%
View More Holdings

News

3 Harbor ETFs Returned Over 10% in January

Despite the cloudy economic outlook, markets started the new year on a high note.

Other symbols: HAPYWINN
1 month ago - ETF Trends

Future Markets Research Releases Commentary on InnoCan Pharma, a Leading Pharma-CBD Player Poised to Disrupt the Market

LONDON--(BUSINESS WIRE)---- $INNO #biotech--The Future Markets Research Tank (FMRT) is proud to release market commentary on InnoCan Pharma, a leading pharma and CBD player poised to disrupt multiple ...

7 months ago - Business Wire

The Future Markets Research Releases Market Commentary on Innocan Pharma, an up-and-coming Leader in CBD Veterinary Solutions

LONDON--(BUSINESS WIRE)---- $INNO #CBD--PESG Research, a research group under the Future Markets Research Tank (FMRT), in proud to release market commentary on Innocan Pharma, an up-and-coming leader ...

1 year ago - Business Wire

Deep Dive: This new competitor to the ARK Innovation ETF focuses on disruptive companies but aims to reduce volatility

Harbor Capital Advisors of Chicago, which manages $62 billion in active strategies, is switching gears, having opened six exchange traded funds in September. The goal is to mitigate the type of volati...

1 year ago - Market Watch

Harbor Capital Advisors Expands ETF Suite with Corporate Culture Leaders Strategy

CHICAGO--(BUSINESS WIRE)--Harbor Capital Advisors, Inc. (“Harbor Capital”) today launched the Harbor Corporate Culture Leaders ETF (HAPY), which aims to capture the alpha generated by companies with t...

Other symbols: HAPYHGERSIFISIHYWINN
1 year ago - Business Wire

Harbor Launches ‘ARKK' Rival

The new ETF relies on multiple managers to select the stocks of 'disruptive' companies.

1 year ago - ETFcom

Harbor Launches Disruptive Innovation ETF, INNO

Harbor Capital Advisors, Inc. launched the Harbor Disruptive Innovation ETF (INNO) today. This is the third actively managed, fully transparent ETF introduced by Harbor.

1 year ago - ETF Trends